Darren S. Cline - 23 Jun 2025 Form 3 Insider Report for Xenon Pharmaceuticals Inc. (XENE)

Signature
/s/ Nathaniel Adams, Attorney-in-fact
Issuer symbol
XENE
Transactions as of
23 Jun 2025
Net transactions value
$0
Form type
3
Filing time
24 Jun 2025, 21:33:09 UTC
Previous filing
09 Jun 2025
Next filing
09 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cline Darren S Chief Commercial Officer 3650 GILMORE WAY, BURNABY, BRITISH COLUMBIA, CANADA /s/ Nathaniel Adams, Attorney-in-fact 25 Jun 2025 0001633639

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding XENE No securities are beneficially owned. 0 23 Jun 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding XENE No securities are beneficially owned. 23 Jun 2025 N/A 0 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Not applicable.